The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 26, Issue 2, 2012, Pages 171-187

  Vaxillaire, Martine ^a   Bonnefond, Amélie ^a   Froguel, Philippe ^a,b  

^a UNIV LILLE   (France)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

genetics; insulin secretion; MODY; monogenic diabetes; mutation; neonatal diabetes mellitus; pancreatic insufficiency; pancreatic cell; pharmacogenetics; type 2 diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; PREPROINSULIN;

ALLELE; ARTICLE; AUTOIMMUNITY; CELL FUNCTION; CLINICAL PRACTICE; DIABETES MELLITUS; ENDOPLASMIC RETICULUM; GENE; GENE LOCUS; GENE MUTATION; GENE THERAPY; GENETIC HETEROGENEITY; GENETIC SCREENING; GENETIC VARIABILITY; GENOME IMPRINTING; HUMAN; INHERITANCE; INSULIN SYNTHESIS; INTRAUTERINE GROWTH RETARDATION; MISSENSE MUTATION; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATIENT CARE; PHARMACOGENETICS; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATION INITIATION; VERY LOW BIRTH WEIGHT;

EID: 84859564568     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2011.12.001     Document Type: Review

References (108)

1. M. Polak, and J. Shield Neonatal and very-early-onset diabetes mellitus Seminars in Neonatalogy 9 2004 59 65 (Pubitemid 38112120)
2. L. Aguilar-Bryan, and J. Bryan Neonatal diabetes mellitus Endocrine Reviews 29 2008 265 291 (Pubitemid 351679699)
3. J. Stoy, S.A.W. Greeley, and V.P. Paz Diagnosis and treatment of neonatal diabetes: an United States experience Pediatric Diabetes 9 2008 450 459
4. A.S. Slingerland, B.M. Shields, and S.E. Flanagan Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births Diabetologia 52 2009 1683 1685
5. M. Vaxillaire, A. Bonnefond, and P. Froguel Breakthroughs in monogenic diabetes genetics: from pediatric forms to young adulthood diabetes Pediatric Endocrinology Reviews 6 2009 405 417
6. I.K. Temple, R.J. Gardner, and D.J. Mackay Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes Diabetes 49 2000 1359 1366 (Pubitemid 30624238)
7. A.T. Hattersley, J. Bruining, and J. Shield The diagnosis and management of monogenic diabetes in children and adolescents Pediatric Diabetes 10 2009 33 42
8. S.A. Greeley, R.N. Naylor, and L.H. Philipson Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment Current Diabetic Reports 11 2011 519 532
9. E.L. Edghill, A.L. Gloyn, and A. Goriely Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings Journal of Clinical Endocrinology and Metabolism 92 2007 1773 1777 (Pubitemid 46997187)
10. A.P. Babenko, M. Polak, and H. Cavé Activating mutations in the ABCC8 gene in neonatal diabetes mellitus The New England Journal of Medicine 355 2006 456 466 (Pubitemid 44162273)
11. A.L. Gloyn, E.R. Pearson, and J.F. Antcliff Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes The New England Journal of Medicine 350 2004 1838 1849 (Pubitemid 38917250)
12. S. Ellard, S.E. Flanagan, and C.A. Girard Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects American Journal of Human Genetics 81 2007 375 382 (Pubitemid 47236084)
13. I. Garin, E.L. Edghill, and I. Akerman Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis Proceedings of National Academic Sciences of the United States of America 107 2010 3105 3110
14. D.A. Stoffers, N.T. Zinkin, and V. Stanojevic Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence Nature Genetics 15 1997 106 110 (Pubitemid 27014961)
15. M. Nicolino, K.C. Claiborn, and V. Senée A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency Diabetes 59 2010 733 740
16. P.R. Njolstad, O. Sovik, and A. Cuesta-Munoz Neonatal diabetes mellitus due to complete glucokinase deficiency The New England Journal of Medicine 344 2001 1588 1592 (Pubitemid 32479911)
17. R.J. Gardner, D.J. Mackay, and A.J. Mungall An imprinted locus associated with transient neonatal diabetes mellitus Human Molecular Genetics 9 2000 589 596 (Pubitemid 30154017)
18. D.J. Mackay, S.E. Boonen, and J. Clayton-Smith A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus Human Genetics 120 2006 262 269 (Pubitemid 44204015)
19. D.J. Mackay, J.L. Callaway, and S.M. Marks Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57 Nature Genetics 40 2008 949 951
20. S.E. Flanagan, E.L. Edghill, and A.L. Gloyn Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype Diabetologia 49 2006 1190 1197
21. M. Vaxillaire, A. Dechaume, and K. Busiah New ABCC8 mutations in relapsing neonatal diabetes and clinical features Diabetes 56 2007 1737 1741 (Pubitemid 46842623)
22. C.G. Nichols KATP channels as molecular sensors of cellular metabolism Nature 440 2006 470 476
23. J. Bryan, A. Crane, and W. Vila-Carriles Insulin secretagogues, sulfonylurea receptors and K(ATP) channels Current Pharmaceutical Design 11 2005 2699 2716 (Pubitemid 41051879)
24. + channels and disease: from molecule to malady American Journal of Physiology. Endocrinology and Metabolism 293 2007 E880 E889
25. A.T. Hattersley, and F.M. Ashcroft Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy Diabetes 54 2005 2503 2513 (Pubitemid 41233571)
26. A.L. Gloyn, C. Diatloff-Zito, and E.L. Edghill KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features European Journal Human Genetics 14 2006 824 830 (Pubitemid 43923367)
27. P. Proks, K. Shimomura, and T.J. Craig Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome Human Molecular Genetics 16 2007 2011 2019 (Pubitemid 47354884)
28. S.A. Greeley, S.E. Tucker, and R.N. Naylor Neonatal diabetes mellitus: a model for personalized medicine Trends in Endocrinology and Metabolism 21 2010 464 472
29. R.H. Clark, J.S. McTaggart, and R. Webster Muscle dysfunction caused by a KATP channel mutation in neonatal diabetes is neuronal in origin Science 329 2010 458 461
30. E.R. Pearson, I. Flechtner, and P.R. Njolstad Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations The New England Journal of Medicine 355 2006 467 477 (Pubitemid 44162274)
31. A.S. Slingerland, W. Hurkx, and K. Noordam Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation Diabetic Medicine 25 2008 277 281 (Pubitemid 351322710)
32. D. Iafusco, C. Bizzarri, and F. Cadario No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes Diabetologia 54 2011 2736 2738
33. A. Mohamadi, L.M. Clark, and P.H. Lipkin Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM Pediatric Diabetes 11 2010 203 207
34. M.T. Malecki, J. Skupien, and T. Klupa Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating mutations: evidence for improvement in insulin sensitivity Diabetes Care 30 2007 147 149 (Pubitemid 46052514)
35. J.P. Riveline, E. Rousseau, and Y. Reznik Clinical and metabolic features of adult-onset diabetes caused by ABCC8 mutations Diabetes Care 35 2010 248 251
36. S.A. Greeley, P.M. John, and A.N. Winn The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes Diabetes Care 34 2011 622 627
37. J. Stoy, E.L. Edghill, and S.E. Flanagan Insulin gene mutations as a cause of permanent neonatal diabetes Proceedings of National Academic Sciences of the United States of America 104 2007 15040 15044 (Pubitemid 47619589)
38. M. Polak, A. Dechaume, and H. Cavé Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group Diabetes 57 2008 1115 1119
39. J. Stoy, D.F. Steiner, and S.Y. Park Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene Reviews in Endocrinology and Metabolic Disorder 11 2010 205 215
40. A. Molven, M. Ringdal, and A.M. Nordbø Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes Diabetes 57 2008 1131 1135
41. G. Meur, A. Simon, and N. Harun Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention Diabetes 59 2010 653 661
42. T.W. Boesgaard, S. Pruhova, and E.A. Andersson Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY) BMC Medical Genetics 11 2010 42 45
43. M. Liu, I. Hodish, and C.J. Rhodes Proinsulin maturation, misfolding, and proteotoxicity Proceedings of National Academic Sciences of the United States of America 104 2007 15841 15846 (Pubitemid 350035386)
44. S. Rajan, S.C. Eames, and S.Y. Park In vitro processing and secretion of mutant insulin proteins that cause permanent neonatal diabetes American Journal of Physiology. Endocrinology Metabolism 298 2010 E403 E410
45. J. Wang, T. Takeuchi, and S. Tanaka A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse Journal of Clinical Investigation 103 1999 27 37 (Pubitemid 29031160)
46. A. Bonnefond, G. Lomberk, and N. Buttar Disruption of a novel KLF-p300-regulated pathway for insulin biosynthesis revealed by studies of the c.-331 INS mutation found in neonatal diabetes mellitus The Journal of Biology Chemistry 286 2011 28414 28424
47. B. Neve, M.E. Fernandez-Zapico, and V. Ashkenazi-Katalan Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function Proceedings of National Academic Sciences of the United States of America 102 2005 4807 4812 (Pubitemid 40471535)
48. K.S. Small, A.K. Hedman, and E. Grundberg Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes Nature Genetics 43 2011 561 564
49. A. Bonnefond, E. Durand, and O. Sand Molecular diagnosis of neonatal diabetes mellitus using next-generation sequencing of the whole exome PLoS One 5 2010 e13630
50. S.S. Fajans, and G.I. Bell MODY: history, genetics, pathophysiology, and clinical decision making Diabetes Care 34 2011 1878 1884
51. M. Vaxillaire, and P. Froguel Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes Endocrine Reviews 29 2008 254 264 (Pubitemid 351679698)
52. R. Murphy, S. Ellard, and A.T. Hattersley Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes National Clinical Practice. Endocrinology & Metabolism 4 2008 200 213 (Pubitemid 351430925)
53. B.M. Shields, S. Hicks, and M.H. Shepherd Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53 2010 2504 2508
54. P. Froguel, H. Zouali, and N. Vionnet Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus The New England Journal of Medicine 328 1993 697 702 (Pubitemid 23073372)
55. K.K. Osbak, K. Colclough, and C. Saint-Martin Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia Human Mutation 30 2009 1512 1526
56. G. Velho, P. Froguel, and K. Clement Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young Lancet 340 1992 444 448
57. M.M. Byrne, J. Sturis, and K. Clement Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations Journal of Clinical Investigation 93 1994 1120 1130 (Pubitemid 24087166)
58. G. Velho, K.F. Petersen, and G. Perseghin Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects Journal of Clinical Investigation 98 1996 1755 1761 (Pubitemid 26359191)
59. G. Velho, A.T. Hattersley, and P. Froguel Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity Diabetologia 43 2000 1060 1063 (Pubitemid 30655727)
60. S. Ellard, and K. Colclough Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young Human Mutatation 27 2006 854 869 (Pubitemid 44336935)
61. M.A. Maestro, C. Cardalda, and S.F. Boj Distinct roles of HNF1 beta, HNF1 alpha, and HNF4 alpha in regulating pancreas development, beta-cell function and growth Endocrine Development 12 2007 33 45
62. E.R. Pearson, S.F. Boj, and A.M. Steele Macrosomia and Hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene PLoS Medicine 4 2007 e118
63. C. Bellanne-Chantelot, D. Chauveau, and J.F. Gautier Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations Annals of Internal Medicine 140 2004 510 517
64. C.P. Thomas, J.C. Erlandson, and E.L. Edghill A genetic syndrome of chronic renal failure with multiple renal cysts and early onset diabetes Kidney International 74 2008 1094 1099
65. E.L. Edghill, C. Bingham, and S. Ellard Mutations in hepatocyte nuclear factor-1beta and their related phenotypes Journal of Medical Genetics 43 2006 84 90 (Pubitemid 43099997)
66. C. Bellanne-Chantelot, S. Clauin, and D. Chauveau Large genomic rearrangements in the hepatocyte nuclear factor-1{beta} (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5 Diabetes 54 2005 3126 3132 (Pubitemid 43334365)
67. T. Yorifuji, K. Kurokawa, and M. Mamada Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism Journal of Clinical Endocrinology and Metabolism 89 2004 2905 2908 (Pubitemid 38766383)
68. E.L. Edghill, C. Bingham, and A.S. Slingerland Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development Diabetic Medicine 23 2006 1301 1306 (Pubitemid 44787792)
69. D.A. Stoffers, J. Ferrer, and W.L. Clarke Early-onset type-II diabetes mellitus (MODY4) linked to IPF1 Nature Genetics 17 1997 138 139
70. O. Rubio-Cabezas, J.A.L. Minton, and I. Kantor Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities Diabetes 59 2010 2326 2331
71. S. Ellard, C. Bellanné-Chantelot, and A.T. Hattersley Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young Diabetologia 51 2008 546 553
72. A. Stride, M. Vaxillaire, and T. Tuomi The genetic abnormality in the beta cell determines the response to an oral glucose load Diabetologia 45 2002 427 435 (Pubitemid 34267366)
73. D. Martin, C. Bellanné-Chantelot, and I. Deschamps Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations (MODY2) Diabetes Care 31 2008 1321 1323
74. E.R. Pearson, B.J. Starkey, and R.J. Powell Genetic cause of hyperglycaemia and response to treatment in diabetes Lancet 362 2003 1275 1281 (Pubitemid 37324255)
75. M. Shepherd, E.R. Pearson, and J. Houghton No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas Diabetes Care 26 2003 3191 3192 (Pubitemid 37339526)
76. K.R. Guertin, and J. Grimsby Small molecule glucokinase activators as glucose lowering agents: a new paradigm for diabetes therapy Current Medicinal Chemistry 13 2006 1839 1843 (Pubitemid 43871760)
77. A.P. Reiner, M.J. Barber, and Y. Guan Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1α are associated with C-reactive protein American Journal of Human Genetics 82 2008 1193 1201
78. K.R. Owen, G. Thanabalasingham, and T.J. James Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations Diabetes Care 33 2010 1919 1924
79. G. Thanabalasingham, N. Shah, and M. Vaxillaire A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes Diabetologia 54 2011 2801 2810
80. R.E. Besser, M.H. Shepherd, and T.J. McDonald Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes Diabetes Care 34 2011 286 291
81. A. Bonnefond, P. Froguel, and M. Vaxillaire The emerging genetics of type 2 diabetes Trends in Molecular Medicine 16 2010 407 416
82. A.I. Tarasov, T.J. Nicolson, and J.P. Riveline A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults Diabetes 57 2008 1595 1604
83. A. Hartemann-Heurtier, A. Simon, and C. Bellanne-Chantelot Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes Diabetes Metabolism 35 2009 233 235
84. H. Huopio, T. Otonkoski, and I. Vauhkonen A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1 Lancet 361 2003 301 307 (Pubitemid 36126191)
85. S.E. Flanagan, A.M. Patch, and D.J. Mackay Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood Diabetes 56 2007 1930 1937 (Pubitemid 47025462)
86. T. Klupa, I. Kowalska, and K. Wyka Mutations in the ABCC8 (SUR1 subunit of the K(ATP) channel) gene are associated with a variable clinical phenotype Clinical Endocrinology 71 2009 358 362
87. T. Yorifuji, K. Nagashima, and K. Kurokawa The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus Journal of Clinical Endocrinology and Metabolism 90 2005 3174 3178 (Pubitemid 41014271)
88. Z. Landau, J. Wainstein, and A. Hanukoglu Sulfonylurea-responsive diabetes in childhood Journal of Pediatrics 150 2007 553 555 (Pubitemid 46602349)
89. S.J. Chan, S. Seino, and P.A. Gruppuso A mutation in the B chain coding region is associated with impaired proinsulin conversion in a family with hyperproinsulinemia Proceedings of National Academic Sciences of the United States of America 84 1987 2194 2197 (Pubitemid 17075837)
90. M.E. Travers, and M.I. McCarthy Type 2 diabetes and obesity: genomics and the clinic Human Genetics 130 2011 41 58
91. B.F. Voight, L.J. Scott, and V. Steinthorsdottir Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis Nature Genetics 42 2010 579 589
92. J. Holmkvist, C. Cervin, and V. Lyssenko Common variants in HNF-1 alpha and risk of type 2 diabetes Diabetologia 49 2006 2882 2891 (Pubitemid 44733934)
93. W. Winckler, M.N. Weedon, and R.R. Graham Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes Diabetes 56 2007 685 693 (Pubitemid 46348464)
94. B.L. Triggs-Raine, R.D. Kirkpatrick, and S.L. Kelly HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community Proceedings of National Academic Sciences of the United States of America 99 2002 4614 4619 (Pubitemid 34286033)
95. J. Gudmundsson, P. Sulem, and V. Steinthorsdottir Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes Nature Genetics 39 2007 977 983 (Pubitemid 47185170)
96. J.S. Kasper, and E.A. Giovannucci Meta-analysis of diabetes mellitus and the risk of prostate cancer Cancer Epidemiology, Biomarkers & Prevention 15 2006 2056 2062 (Pubitemid 44877026)
97. E.H. Hani, P. Boutin, and E. Durand Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in caucasians Diabetologia 41 1998 1511 1515 (Pubitemid 28551623)
98. M.J. Riedel, D.C. Steckley, and P.E. Light Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes Human Genetics 116 2005 133 145 (Pubitemid 40173997)
99. A.L. Gloyn, M.N. Weedon, and K.R. Owen Large scale association studies of variants in genes encoding the pancreatic beta-cell K-ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with increased risk of Type 2 Diabetes 52 2003 568 572 (Pubitemid 36173218)
100. J.C. Florez, N. Burtt, and P.I. de Bakker Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region Diabetes 53 2004 1360 1368 (Pubitemid 38569024)
101. Y. Feng, G. Mao, and X. Ren Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients Diabetes Care 31 2008 1939 1944
102. K.S. Hamming, D. Soliman, and L.C. Matemisz Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel Diabetes 58 2009 2419 2424
103. M.S. Sandhu, M.N. Weedon, and K.A. Fawcett Common variants in WFS1 confer risk of type 2 diabetes Nature Genetics 39 2007 951 953 (Pubitemid 47185173)
104. P.W. Franks, O. Rolandsson, and S.L. Debenham Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations Diabetologia 51 2008 458 463
105. M. Vaxillaire, J. Veslot, and C. Dina Impact of common type 2 diabetes risk polymorphisms in the D.E.S.I.R. prospective study Diabetes 57 2008 244 254
106. M.N. Weedon, V.J. Clark, and Y. Qian A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses American Journal Human Genetics 79 2006 991 1001 (Pubitemid 44853472)
107. J. Dupuis, C. Langenberg, and I. Prokopenko New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk Nature Genetics 42 2010 105 116
108. E. Ingelsson, C. Langenberg, and M.F. Hivert Detailed physiologic characterization reveals diverse mechanisms for novel genetic loci regulating glucose and insulin metabolism in humans Diabetes 59 2010 1266 1275